Accession Number: | 0000899243-20-029337 |
Date: | 2020-10-27 |
Issuer: | SPERO THERAPEUTICS, INC. (SPRO) |
Original Submission Date: |
THOMAS FRANK E
C/O SPERO THERAPEUTICS, INC.
675 MASSACHUSETTS AVENUE, 14TH FLOOR
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 13.52 | 2020-10-27 | deemed execution date | A | 7,500 (a) | 2030-10-27 | common stock 7,500 | $13.52 | 7,500 | direct |
ID | footnote |
---|---|
f1 | the shares underlying this option will vest and become exercisable in full on october 27, 2021 subject to the reporting person's continued service as a director through the vesting date. |